Læknablaðið : fylgirit - 01.05.1978, Qupperneq 28

Læknablaðið : fylgirit - 01.05.1978, Qupperneq 28
A. Kolbeinsson, E. AUander, O. Björnsson, O. Olafsson, N. Sigfússon, J. Thorsteinsson. Intr oduction: In a long term population study, which was started in 1967 by the Icelandic Heart Associ- ation, the prevalence and incidence of RF in the population of Reykjavik and suburbs was investi- gated. The RF is considered as a risk factor and information on its prevalence and incidense is of epidemiological significance. The knowledge in this field may also contribute to better under- standing of the nature of the rheumatoid arthritis. Mater ial: The population selected for this study, both men and women, were divided in three groups for either sex, labeled A, B and C (see table I). The selection was based on date of birth, this the group B consisted of women borne on the 1., 4., 7., 10. etc. day of each month. There were apprax. 3000 people in each group. The first stage of investigation was performed from the fall '68 to the fall '69. This stage consisted of the B group (women) and the response was 707o. The second stage of the investigation was performed three years later '71 - '72. Then the group B was investigated second time and the group C for the first time. The response in the second investigation of women was 74%. The total number of sera investigated for rheumatoid factor was 4093 (1% of the sera collected were not investigated for RF.) Table II shows in the first column the 6 age groups of women according to date of birth, devided into five year intervals, in the second stage of investigation (1971). The highest number of participants are in the two middle age groups. In the third column of the table is the number of women investigated in group B, first and second stage and in group C investigated for the first time at the second stage of this study. , (1971). Most of the women in the B group at the second stage were investigated for second time, but some for the first time (those who did not respond to invitation to the first stage of the study). M ethods: Two methods were used for determining the THE PREVALENCE AND INCIDENCE OF RHEUMATOID FACTOR (RF) AMONG FEMALE POPULATION IN ICELAND RF. Both Waaler-Rose (WR) and akrylfixation test (AFt). Right after collection the sera were frosen down and stored at minus 22C. The storage time of sera varied from 6 months to 30 months. Two technicians performed the test for RF. One did the first stage and the other the second stage. Two sera with positive WR titer were used as controls. These controls were compared with an intemational reference preparation of RF serum obtained from Statens Seruminstitut Copenhagen. R esults: Results from the first stage of this study has been published and this paper deals with results from investigation of RF in group B and C females in the second stage of the study. Diagram III. shows the prevalence of Waaler Rose titer equal or gradet 1/20 in the two groups of women. Group B first stage and Group B-C second stage. The intermitted line in this diagram shows the results from the first stage Group-B and the solid line the results from the second stage. Group B-C. These curves show the prevalence of RF show similar trends and the prevalence of R F increases with age. Diagram IV. shows the prevalence of AFT titer, equal or greater than 1/20 in the same way and in the same groups as diagram III shows the WR titer. The curves from first and second stage do not agree in the same way as the curves for WR titer did. The curve from first stage is 1/2-1% lower than the curves from second stage. This may be explained by the fact that two different technicians performed the AFT tests at each stage, and the tests are rather difficult to read. Table V. shows the changes in WR titers from positive to negative reaction. In this table the lowest positive titer is 1/10. 35 were positive in the first stage and 34 were positive in second stage. From 1734 negatives in first stage 19 were positive or 140 in the second stage. The estimated age conditioned yearly brutto incidence of RF in this population will be approxi- mately 0. 3%. Compared to the yearly aged condition netto incidence of RF 0.1%. 26
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158

x

Læknablaðið : fylgirit

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið : fylgirit
https://timarit.is/publication/991

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.